Congenital hydrocephalus

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2185OMIM:618570Q03.1Q03.8Q03.9
Who is this for?
Show terms as
29Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Congenital hydrocephalus is a condition present at birth characterized by an abnormal accumulation of cerebrospinal fluid (CSF) within the ventricles of the brain, leading to increased intracranial pressure and enlargement of the head. This occurs when the normal flow, absorption, or production of CSF is disrupted. The condition primarily affects the central nervous system and can result in progressive enlargement of the skull in infants (macrocephaly), bulging of the fontanelles, irritability, vomiting, downward deviation of the eyes ("sunset sign"), and developmental delays. Subtypes include congenital hydrocephalus due to aqueductal stenosis (Dandy-Walker malformation and other obstructive forms), as well as communicating forms where CSF absorption is impaired. Congenital hydrocephalus can occur as an isolated malformation or as part of a broader syndrome. Causes include genetic mutations (such as L1CAM mutations in X-linked hydrocephalus), neural tube defects, intrauterine infections (e.g., toxoplasmosis, cytomegalovirus), and intracranial hemorrhage. In many cases, the etiology remains unknown. If left untreated, the progressive accumulation of CSF can cause significant brain damage, cognitive impairment, motor deficits, and vision problems. The primary treatment for congenital hydrocephalus is surgical intervention. The most common procedure is the placement of a ventriculoperitoneal (VP) shunt, which diverts excess CSF from the brain ventricles to the peritoneal cavity for absorption. Endoscopic third ventriculostomy (ETV) is an alternative surgical approach, particularly for obstructive forms, which creates a new pathway for CSF drainage. Early diagnosis and treatment are critical for optimizing neurodevelopmental outcomes. Long-term follow-up is essential, as shunt complications including infection, obstruction, and over-drainage are common and may require revision surgeries. Prognosis varies widely depending on the underlying cause, severity, associated malformations, and timeliness of treatment.

Clinical phenotype terms— hover any for plain English:

Small cerebral cortexHP:0002472Abnormal cortical gyrationHP:0002536ColpocephalyHP:0030048Macular hypoplasiaHP:0001104LissencephalyHP:0001339
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Congenital hydrocephalus.

View clinical trials →

No actively recruiting trials found for Congenital hydrocephalus at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Congenital hydrocephalus community →

Specialists

Showing 25 of 29View all specialists →
CD
Cornelis J Drost
Specialist
PI on 1 active trial
SM
Satish Krishnamurthy, MD
SYRACUSE, NY
Specialist
PI on 1 active trial
MN
Madoka Nakajima
Specialist
2 Congenital hydrocephalus publications
SJ
Sheng Chih Jin
Specialist
5 Congenital hydrocephalus publications
AK
Adam J Kundishora
NEW HAVEN, CT
Specialist
3 Congenital hydrocephalus publications
SA
Seth L Alper
AURORA, IL
Specialist
3 Congenital hydrocephalus publications
KS
Koichiro Sakamoto
Specialist
2 Congenital hydrocephalus publications
MM
Masakazu Miyajima
Specialist
2 Congenital hydrocephalus publications
KK
Kaito Kawamura
Specialist
2 Congenital hydrocephalus publications
AK
Akihide Kondo
Specialist
2 Congenital hydrocephalus publications
EK
Emre Kiziltug
ANN ARBOR, MI
Specialist
2 Congenital hydrocephalus publications
SR
Stephanie M Robert
PHILADELPHIA, PA
Specialist
2 Congenital hydrocephalus publications
AS
Amrita K Singh
Specialist
2 Congenital hydrocephalus publications
KK
Kristopher T Kahle
CINCINNATI, OH
Specialist
7 Congenital hydrocephalus publications
EN
Eri Nakamura
CHERRY HILL, NJ
Specialist
2 Congenital hydrocephalus publications
PD
Phan Q Duy
Specialist
5 Congenital hydrocephalus publications
GA
Garrett Allington
Specialist
5 Congenital hydrocephalus publications
RM
Robin S Roberts, MTech
Specialist
PI on 2 active trials
HM
Haresh Kirpalani, MD, MSc
PHILADELPHIA, PA
Specialist
PI on 2 active trials
TB
Thierry BIENVENU
Specialist
PI on 1 active trial27 Congenital hydrocephalus publications
EM
Elizabeth Asztalos, MD, MSc
Specialist
PI on 1 active trial
NM
Nancy Heddle, MSc
Specialist
PI on 1 active trial
RM
Robin K Whyte, MD
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Congenital hydrocephalus.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Congenital hydrocephalusForum →

No community posts yet. Be the first to share your experience with Congenital hydrocephalus.

Start the conversation →

Latest news about Congenital hydrocephalus

No recent news articles for Congenital hydrocephalus.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Congenital hydrocephalus

What is Congenital hydrocephalus?

Congenital hydrocephalus is a condition present at birth characterized by an abnormal accumulation of cerebrospinal fluid (CSF) within the ventricles of the brain, leading to increased intracranial pressure and enlargement of the head. This occurs when the normal flow, absorption, or production of CSF is disrupted. The condition primarily affects the central nervous system and can result in progressive enlargement of the skull in infants (macrocephaly), bulging of the fontanelles, irritability, vomiting, downward deviation of the eyes ("sunset sign"), and developmental delays. Subtypes include

At what age does Congenital hydrocephalus typically begin?

Typical onset of Congenital hydrocephalus is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Congenital hydrocephalus?

25 specialists and care centers treating Congenital hydrocephalus are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.